• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体痴呆:病理亚型的重新分类以及与帕金森病或阿尔茨海默病的界限

Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease.

作者信息

Iseki Eizo

机构信息

Department of Psychiatry, Yokohama City University School of Medicine, Kanazawa-ku, Yokohama, Japan.

出版信息

Neuropathology. 2004 Mar;24(1):72-8. doi: 10.1111/j.1440-1789.2003.00530.x.

DOI:10.1111/j.1440-1789.2003.00530.x
PMID:15068176
Abstract

The present study is an attempt to reclassify the pathological subtypes of DLB based on both Lewy pathology and Alzheimer pathology, and to clarify the pathological boundary between DLB and Parkinson's disease (PD) or Alzheimer's disease (AD) in autopsied cases, using pathological and immunohistochemical methods. Dementia with Lewy bodies was classified into the limbic type and neocortical type according to the degree of Lewy pathology, including Lewy bodies (LB) and LB-related neurites, by our staging and was classified into the pure form, common form and AD form according to the degree of Alzheimer pathology including NFT and amyloid deposits by Braak staging. These combined subtypes were lined up on a spectrum not only with Lewy pathology but also with other DLB-related pathologies including Alzheimer pathology, neuronal loss in the substantia nigra, spongiform change in the transentorhinal cortex and LB-related neurites in the CA2-3 region. There were some similarities in both Lewy pathology and other DLB-related pathologies between PD and DLB, although Lewy pathology of PD was below the lowest stage of Lewy pathology. In contrast, AD did not meet the stages of Lewy pathology, and there were also no similarities in other DLB-related pathologies between AD and DLB. In addition, LB of AD showed the characteristics different from those of DLB on the coexistence of LB with NFT. These present findings suggest that DLB has pathological continuity with PD, but can be pathologically differentiated from AD. The present study clarified the pathological entity of DLB, compared with PD and AD.

摘要

本研究旨在基于路易体病理和阿尔茨海默病病理对路易体痴呆(DLB)的病理亚型进行重新分类,并使用病理和免疫组织化学方法,在尸检病例中阐明DLB与帕金森病(PD)或阿尔茨海默病(AD)之间的病理界限。根据路易体病理程度,包括路易体(LB)和与LB相关的神经突,通过我们的分期将路易体痴呆分为边缘型和新皮质型,并根据Braak分期中包括神经原纤维缠结(NFT)和淀粉样蛋白沉积的阿尔茨海默病病理程度分为纯合型、常见型和AD型。这些联合亚型不仅在路易体病理方面,而且在包括阿尔茨海默病病理、黑质神经元丢失、内嗅皮质海绵状改变以及CA2-3区与LB相关的神经突等其他与DLB相关的病理方面,都排列在一个连续谱上。PD和DLB在路易体病理以及其他与DLB相关的病理方面存在一些相似之处,尽管PD的路易体病理低于路易体病理的最低阶段。相比之下,AD不符合路易体病理阶段,并且AD与DLB在其他与DLB相关的病理方面也没有相似之处。此外,AD的LB在与NFT共存时表现出与DLB不同的特征。这些目前的发现表明,DLB与PD存在病理连续性,但在病理上可与AD区分开来。本研究阐明了与PD和AD相比,DLB的病理实体。

相似文献

1
Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease.路易体痴呆:病理亚型的重新分类以及与帕金森病或阿尔茨海默病的界限
Neuropathology. 2004 Mar;24(1):72-8. doi: 10.1111/j.1440-1789.2003.00530.x.
2
Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.路易体痴呆的病理实体及其与阿尔茨海默病的鉴别
Acta Neuropathol. 2004 Aug;108(2):121-8. doi: 10.1007/s00401-004-0869-4. Epub 2004 May 14.
3
Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.阿尔茨海默病与路易体病理并存患者中病理性α-突触核蛋白的分布情况。
Acta Neuropathol. 2016 Mar;131(3):393-409. doi: 10.1007/s00401-015-1526-9. Epub 2015 Dec 31.
4
Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia.形态学特征可将路易体痴呆与伴有和不伴有痴呆的帕金森病区分开来。
J Neural Transm (Vienna). 2023 Jul;130(7):891-904. doi: 10.1007/s00702-023-02660-3. Epub 2023 Jun 12.
5
Lewy body-related alpha-synucleinopathy in the aged human brain.老年人大脑中与路易体相关的α-突触核蛋白病。
J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35. doi: 10.1007/s00702-004-0138-7. Epub 2004 Apr 2.
6
A critical reappraisal of current staging of Lewy-related pathology in human brain.对人类大脑中路易体相关病理学当前分期的批判性重新评估。
Acta Neuropathol. 2008 Jul;116(1):1-16. doi: 10.1007/s00401-008-0406-y. Epub 2008 Jul 1.
7
Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.路易体痴呆显示出严重的路易病理改变但阿尔茨海默病理改变轻微——路易病理改变导致神经元丢失,进而引发进行性痴呆。
Clin Neuropathol. 2002 Nov-Dec;21(6):269-77.
8
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.路易体痴呆与帕金森病痴呆:当前的概念和争议。
J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8.
9
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.帕金森病和阿尔茨海默病大脑中的α-突触核蛋白病理学:发病率和拓扑分布——一项初步研究。
Acta Neuropathol. 2003 Sep;106(3):191-201. doi: 10.1007/s00401-003-0725-y. Epub 2003 Jul 5.
10
Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?帕金森病痴呆与路易体痴呆之间存在形态学差异吗?
Parkinsonism Relat Disord. 2022 Jul;100:24-32. doi: 10.1016/j.parkreldis.2022.05.024. Epub 2022 Jun 3.

引用本文的文献

1
Recruitment of Aβ into α‑Synuclein Condensates Catalyzes Primary Nucleation of α‑Synuclein Aggregation.淀粉样β蛋白(Aβ)进入α-突触核蛋白凝聚物中会催化α-突触核蛋白聚集的初级成核过程。
ACS Cent Sci. 2025 Jul 28;11(8):1481-1491. doi: 10.1021/acscentsci.5c00614. eCollection 2025 Aug 27.
2
Converging pathologies in neurodegeneration: the mechanistic interplay between α-Synuclein and Tau in Alzheimer's and Parkinson's.神经退行性变中的汇聚性病理:阿尔茨海默病和帕金森病中α-突触核蛋白与 Tau 蛋白之间的机制相互作用
Neurol Sci. 2025 Aug 26. doi: 10.1007/s10072-025-08421-2.
3
Biomarkers: Our Path Towards a Cure for Alzheimer Disease.
生物标志物:我们治愈阿尔茨海默病的道路。
Biomark Insights. 2020 Nov 25;15:1177271920976367. doi: 10.1177/1177271920976367. eCollection 2020.
4
α-Synuclein modulates tau spreading in mouse brains.α-突触核蛋白调节小鼠脑中 tau 的扩散。
J Exp Med. 2021 Jan 4;218(1). doi: 10.1084/jem.20192193.
5
Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.路易体痴呆症杏仁核内独特的α-突触核蛋白病理学:对疾病起始和进展的影响。
Acta Neuropathol Commun. 2019 Sep 2;7(1):142. doi: 10.1186/s40478-019-0787-2.
6
α-synuclein in the pathophysiology of Alzheimer's disease.α-突触核蛋白在阿尔茨海默病的病理生理学中的作用。
Mol Neurodegener. 2019 Jun 11;14(1):23. doi: 10.1186/s13024-019-0320-x.
7
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.神经退行性疾病中的蛋白质错误折叠、聚集和构象应变。
Nat Neurosci. 2018 Oct;21(10):1332-1340. doi: 10.1038/s41593-018-0235-9. Epub 2018 Sep 24.
8
The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.杏仁核作为神经退行性疾病中病理性错误折叠的位点
J Neuropathol Exp Neurol. 2018 Jan 1;77(1):2-20. doi: 10.1093/jnen/nlx099.
9
Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci.阿尔茨海默病(AD)在20个与AD相关的基因座中的特异性转录、DNA甲基化和剪接。
Mol Cell Neurosci. 2015 Jul;67:37-45. doi: 10.1016/j.mcn.2015.05.003. Epub 2015 May 21.
10
Alpha-synuclein biology in Lewy body diseases.路易体病中的α-突触核蛋白生物学。
Alzheimers Res Ther. 2014 Oct 27;6(5):73. doi: 10.1186/s13195-014-0073-2. eCollection 2014.